Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Do we know the true mechanism of action of the DPP‐4 inhibitors?
Emilie S. Andersen, Carolyn F. Deacon, Jens J. Holst
Diabetes Obesity and Metabolism (2017) Vol. 20, Iss. 1, pp. 34-41
Closed Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies, David A. D’Alessio, Judith Fradkin, et al.
Diabetes Care (2018) Vol. 41, Iss. 12, pp. 2669-2701
Open Access | Times Cited: 3144
Broadening horizons: the role of ferroptosis in cancer
Xin Chen, Rui Kang, Guido Kroemer, et al.
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 5, pp. 280-296
Closed Access | Times Cited: 1990
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies, David A. D’Alessio, Judith Fradkin, et al.
Diabetologia (2018) Vol. 61, Iss. 12, pp. 2461-2498
Open Access | Times Cited: 1344
Treatment strategies against diabetes: Success so far and challenges ahead
Rubiya Khursheed, Sachin Kumar Singh, Sheetu Wadhwa, et al.
European Journal of Pharmacology (2019) Vol. 862, pp. 172625-172625
Closed Access | Times Cited: 182
SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management
Michaël J.B. van Baar, Charlotte C. van Ruiten, Marcel H.A. Muskiet, et al.
Diabetes Care (2018) Vol. 41, Iss. 8, pp. 1543-1556
Open Access | Times Cited: 170
Identification of novel dipeptidyl peptidase IV (DPP-IV) inhibitory peptides in camel milk protein hydrolysates
Alice B. Nongonierma, Sara Paolella, Priti Mudgil, et al.
Food Chemistry (2017) Vol. 244, pp. 340-348
Open Access | Times Cited: 159
Recently isolated antidiabetic hydrolysates and peptides from multiple food sources: a review
Bababode Adesegun Kehinde, Poorva Sharma
Critical Reviews in Food Science and Nutrition (2018) Vol. 60, Iss. 2, pp. 322-340
Closed Access | Times Cited: 127
Circulating Levels of Soluble Dipeptidyl Peptidase-4 Are Dissociated from Inflammation and Induced by Enzymatic DPP4 Inhibition
Elodie M. Varin, Erin E. Mulvihill, Jacqueline L. Beaudry, et al.
Cell Metabolism (2018) Vol. 29, Iss. 2, pp. 320-334.e5
Open Access | Times Cited: 119
The role of diosgenin in diabetes and diabetic complications
Qingxia Gan, Jin Wang, Hu Ju, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2019) Vol. 198, pp. 105575-105575
Closed Access | Times Cited: 97
The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin
Keizo Kanasaki
Clinical Science (2018) Vol. 132, Iss. 4, pp. 489-507
Open Access | Times Cited: 95
DPP-4 Inhibition and the Path to Clinical Proof
Bo Åhrén
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 86
The molecular basis of the anti-diabetic properties of camel milk
Mohammed Akli Ayoub, Abdul Rasheed Palakkott, Arshida Ashraf, et al.
Diabetes Research and Clinical Practice (2018) Vol. 146, pp. 305-312
Closed Access | Times Cited: 84
The hypoglycemic potential of phenolics from functional foods and their mechanisms
Оксана Головинская, Chin‐Kun Wang
Food Science and Human Wellness (2022) Vol. 12, Iss. 4, pp. 986-1007
Open Access | Times Cited: 58
Food-derived dipeptidyl peptidase IV inhibitory peptides: Production, identification, structure-activity relationship, and their potential role in glycemic regulation
Mingkai Zhang, Ling Zhu, Gangcheng Wu, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 64, Iss. 8, pp. 2053-2075
Closed Access | Times Cited: 42
The importance of glucose‐dependent insulinotropic polypeptide receptor activation for the effects of tirzepatide
Lærke S. Gasbjerg, Mette M. Rosenkilde, Juris J. Meier, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 11, pp. 3079-3092
Closed Access | Times Cited: 24
New insights in the treatment of DKD: recent advances and future prospects
Meimei Zhao, Yongtong Cao, Liang Ma
BMC Nephrology (2025) Vol. 26, Iss. 1
Open Access | Times Cited: 1
Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism
Natasha A. Trzaskalski, Evgenia Fadzeyeva, Erin E. Mulvihill
Clinical Medicine Insights Endocrinology and Diabetes (2020) Vol. 13, pp. 117955142091297-117955142091297
Open Access | Times Cited: 68
Post-transplantation diabetes in kidney transplant recipients: an update on management and prevention
Caterina Conte, Antonio Secchi
Acta Diabetologica (2018) Vol. 55, Iss. 8, pp. 763-779
Closed Access | Times Cited: 65
More than just an enzyme: Dipeptidyl peptidase-4 (DPP-4) and its association with diabetic kidney remodelling
Shreyasi Gupta, Utpal Sen
Pharmacological Research (2019) Vol. 147, pp. 104391-104391
Open Access | Times Cited: 55
Characteristics of Food Protein-Derived Antidiabetic Bioactive Peptides: A Literature Update
Nhung Thi Phuong Nong, Jue‐Liang Hsu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9508-9508
Open Access | Times Cited: 43
Hempseed (Cannabis sativa) protein hydrolysates: A valuable source of bioactive peptides with pleiotropic health-promoting effects
Guillermo Santos‐Sánchez, Ana Isabel Álvarez‐López, Eduardo Ponce‐España, et al.
Trends in Food Science & Technology (2022) Vol. 127, pp. 303-318
Open Access | Times Cited: 36
Mechanistic Study of Novel Dipeptidyl Peptidase IV Inhibitory Peptides from Goat’s Milk Based on Peptidomics and In Silico Analysis
Yulong Wu, Jin Zhang, Ruikai Zhu, et al.
Foods (2024) Vol. 13, Iss. 8, pp. 1194-1194
Open Access | Times Cited: 7
Effect of enzymatic hydrolysis of pulse protein macromolecules to tailor structure for enhanced nutraceutical properties
Zanoor ul Ashraf, Asima Shah, Asir Gani, et al.
LWT (2024) Vol. 205, pp. 116502-116502
Open Access | Times Cited: 6
The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway
Fausto Chiazza, Harald Tammen, Hiranya Pintana, et al.
Cardiovascular Diabetology (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 53
Therapeutic Potential of Peptides Derived from Animal Venoms: Current Views and Emerging Drugs for Diabetes
Aimee Coulter‐Parkhill, Stephen McClean, Victor A. Gault, et al.
Clinical Medicine Insights Endocrinology and Diabetes (2021) Vol. 14
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top